Nutritional research is undergoing a remarkable transformation driven by new technological tools. Because of the complexity of the components present in food and how they may interact with the biochemical networks of living organisms, nutrition cannot be considered a reductionist discipline. More holistic approaches, which are capable of gathering comprehensive, high-throughput amounts of data, appear to best enhance our understanding of the role of food in health and disease. In this context, global metabolite analysis, or ‘metabolomics', is becoming an appealing research tool for nutrigenomics and nutrigenetics scientists. The purpose of the present review is to highlight some potential applications of metabolomics in nutrition research.

Keywords:
Metabolomics, Lipidomics, Food, Diet, Nutrition, Lipids, Metabolites, Mass spectrometry
1.
Nicholson JK, Holmes E, Kinross JM, Darzi AW, Takats Z, Lindon JC: Metabolic phenotyping in clinical and surgical environments. Nature 2012;491:384-392.
2.
Patti GJ, Yanes O, Siuzdak G: Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012;13:263-269.
3.
Fiehn O: Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol 2002;48:155-171.
4.
Nicholson JK, Lindon JC: Systems biology: metabonomics. Nature 2008;455:1054-1056.
5.
Nicholson JK, Wilson ID: Opinion: understanding ‘global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2003;2:668-676.
6.
van der Greef J, Hankemeier T, McBurney RN: Metabolomics-based systems biology and personalized medicine: moving towards n=1 clinical trials? Pharmacogenomics 2006;7:1087-1094.
7.
Bino RJ, Hall RD, Fiehn O, Kopka J, Saito K, Draper J, Nikolau BJ, Mendes P, Roessner-Tunali U, Beale MH, Trethewey RN, Lange BM, Wurtele ES, Sumner LW: Potential of metabolomics as a functional genomics tool. Trends Plant Sci 2004;9:418-425.
8.
Primrose S, Draper J, Elsom R, Kirkpatrick V, Mathers JC, Seal C, Beckmann M, Haldar S, Beattie JH, Lodge JK, Jenab M, Keun H, Scalbert A: Metabolomics and human nutrition. Br J Nutr 2011;105:1277-1283.
9.
Gibney MJ, Walsh M, Brennan L, Roche HM, German B, van Ommen B: Metabolomics in human nutrition: opportunities and challenges. Am J Clin Nutr 2005;82:497-503.
10.
Wishart DS: Metabolomics: applications to food science and nutrition research. Trends Food Sci Tech 2008;19:482-493.
11.
Brennan L: Metabolomics in nutrition research: current status and perspectives. Biochem Soc Trans 2013;41:670-673.
12.
Herrero M, Simo C, Garcia-Canas V, Ibanez E, Cifuentes A: Foodomics: MS-based strategies in modern food science and nutrition. Mass Spectrom Rev 2012;31:49-69.
13.
Cevallos-Cevallos JM, Reyes-De-Corcuera JI: Metabolomics in food science. Adv Food Nutr Res 2012;67:1-24.
14.
Rubio-Aliaga I, Kochhar S, Silva-Zolezzi I: Biomarkers of nutrient bioactivity and efficacy: a route toward personalized nutrition. J Clin Gastroenterol 2012;46:545-554.
15.
Llorach R, Garcia-Aloy M, Tulipani S, Vazquez-Fresno R, Andres-Lacueva C: Nutrimetabolomic strategies to develop new biomarkers of intake and health effects. J Agric Food Chem 2012;60:8797-8808.
16.
Jones DP, Park Y, Ziegler TR: Nutritional metabolomics: progress in addressing complexity in diet and health. Annu Rev Nutr 2012;32:183-202.
17.
Kussmann M, Raymond F, Affolter M: OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 2006;124:758-787.
18.
Manach C, Hubert J, Llorach R, Scalbert A: The complex links between dietary phytochemicals and human health deciphered by metabolomics. Mol Nutr Food Res 2009;53:1303-1315.
19.
Barnes S, Prasain J, Kim H: In nutrition, can we ‘see' what is good for us? Adv Nutr 2013;4:327S-334S.
20.
Dixon RA, Gang DR, Charlton AJ, Fiehn O, Kuiper HA, Reynolds TL, Tjeerdema RS, Jeffery EH, German JB, Ridley WP, Seiber JN: Applications of metabolomics in agriculture. J Agric Food Chem 2006;54:8984-8994.
21.
Simpson MJ, McKelvie JR: Environmental metabolomics: new insights into earthworm ecotoxicity and contaminant bioavailability in soil. Anal Bioanal Chem 2009;394:137-149.
22.
Trenkamp S, Eckes P, Busch M, Fernie AR: Temporally resolved GC-MS-based metabolic profiling of herbicide treated plants treated reveals that changes in polar primary metabolites alone can distinguish herbicides of differing mode of action. Metabolomics 2009;5:277-291.
23.
Sumner LW, Mendes P, Dixon RA: Plant metabolomics: large-scale phytochemistry in the functional genomics era. Phytochemistry 2003;62:817-836.
24.
Bundy JG, Davey MP, Viant MR: Environmental metabolomics: a critical review and future perspectives. Metabolomics 2009;5:3-21.
25.
Stierum R, Heijne W, Kienhuis A, van Ommen B, Groten J: Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals. Toxicol Appl Pharmacol 2005;207:179-188.
26.
Scalbert A, Andres-Lacueva C, Arita M, Kroon P, Manach C, Urpi-Sarda M, Wishart D: Databases on food phytochemicals and their health-promoting effects. J Agric Food Chem 2011;59:4331-4348.
27.
Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E, Bouatra S, Sinelnikov I, Arndt D, Xia J, Liu P, Yallou F, Bjorndahl T, Perez-Pineiro R, Eisner R, Allen F, Neveu V, Greiner R, Scalbert A: HMDB 3.0 - the Human Metabolome Database in 2013. Nucleic Acids Res 2013;41:D801-D807.
28.
Rothwell JA, Urpi-Sarda M, Boto-Ordonez M, Knox C, Llorach R, Eisner R, Cruz J, Neveu V, Wishart D, Manach C, Andres-Lacueva C, Scalbert A: Phenol-Explorer 2.0: a major update of the phenol-explorer database integrating data on polyphenol metabolism and pharmacokinetics in humans and experimental animals. Database (Oxford) 2012;2012:bas031.
29.
Giacomoni F, Fillatre Y, Rothwell JA, Knox C, Eisner R, Cesaire D, Quintana M, Sébédio JL, Comte B, Pujos-Guillot E, Manach C: Phytohub: A new knowledge database on dietary phytochemicals and their human metabolites. Integrative Approaches in Nutrition Research, 2nd International Congress of Translational Research in Human Nutrition, Clermont-Ferrand, 2013.
30.
Velimirov A, Huber M, Lauridsen C, Rembialkowska E, Seidel K, Bugel S: Feeding trials in organic food quality and health research. J Sci Food Agric 2010;90:175-182.
31.
Fernie AR, Schauer N: Metabolomics-assisted breeding: a viable option for crop improvement? Trends Genet 2009;25:39-48.
32.
Barros E, Lezar S, Anttonen MJ, van Dijk JP, Rohlig RM, Kok EJ, Engel KH: Comparison of two GM maize varieties with a near-isogenic non-GM variety using transcriptomics, proteomics and metabolomics. Plant Biotechnol J 2010;8:436-451.
33.
Vallverdu-Queralt A, Medina-Remon A, Casals-Ribes I, Amat M, Lamuela-Raventos RM: A metabolomic approach differentiates between conventional and organic ketchups. J Agric Food Chem 2011;59:11703-11710.
34.
Strobel C, Jahreis G, Kuhnt K: Survey of n-3 and n-6 polyunsaturated fatty acids in fish and fish products. Lipids Health Dis 2012;11:144.
35.
Novotna H, Kmiecik O, Galazka M, Krtkova V, Hurajova A, Schulzova V, Hallmann E, Rembialkowska E, Hajslova J: Metabolomic fingerprinting employing DART-TOFMS for authentication of tomatoes and peppers from organic and conventional farming. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2012;29:1335-1346.
36.
Beleggia R, Platani C, Papa R, Di Chio A, Barros E, Mashaba C, Wirth J, Fammartino A, Sautter C, Conner S, Rauscher J, Stewart D, Cattivelli L: Metabolomics and food processing: from semolina to pasta. J Agric Food Chem 2011;59:9366-9377.
37.
Heuberger AL, Lewis MR, Chen MH, Brick MA, Leach JE, Ryan EP: Metabolomic and functional genomic analyses reveal varietal differences in bioactive compounds of cooked rice. PLoS ONE 2010;5:e12915.
38.
Lloyd AJ, Beckmann M, Haldar S, Seal C, Brandt K, Draper J: Data-driven strategy for the discovery of potential urinary biomarkers of habitual dietary exposure. Am J Clin Nutr 2013;97:377-389.
39.
O'Sullivan A, Gibney MJ, Brennan L: Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies. Am J Clin Nutr 2011;93:314-321.
40.
Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW: Urinary 1-methylhistidine is a marker of meat consumption in Black and in White California Seventh-day Adventists. Am J Epidemiol 2000;152:752-755.
41.
Tucker KL, Smith CE, Lai CQ, Ordovas JM: Quantifying diet for nutrigenomic studies. Annu Rev Nutr 2013;33:349-371.
42.
Garneau V, Rudkowska I, Paradis AM, Godin G, Julien P, Perusse L, Vohl MC: Omega-3 fatty acids status in human subjects estimated using a food frequency questionnaire and plasma phospholipids levels. Nutr J 2012;11:46.
43.
Pujos-Guillot E, Hubert J, Martin JF, Lyan B, Quintana M, Claude S, Chabanas B, Rothwell JA, Bennetau-Pelissero C, Scalbert A, Comte B, Hercberg S, Morand C, Galan P, Manach C: Mass spectrometry-based metabolomics for the discovery of biomarkers of fruit and vegetable intake: citrus fruit as a case study. J Proteome Res 2013, E-pub ahead of print.
44.
Galland L: Diet and inflammation. Nutr Clin Pract 2010;25:634-640.
45.
Snigdha S, Astarita G, Piomelli D, Cotman CW: Effects of diet and behavioral enrichment on free fatty acids in the aged canine brain. Neuroscience 2012;202:326-333.
46.
Willett WC: Dietary fats and coronary heart disease. J Intern Med 2012;272:13-24.
47.
Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Martinez-Gonzalez MA: Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013;368:1279-1290.
48.
Tsivgoulis G, Judd S, Letter AJ, Alexandrov AV, Howard G, Nahab F, Unverzagt FW, Moy C, Howard VJ, Kissela B, Wadley VG: Adherence to a Mediterranean diet and risk of incident cognitive impairment. Neurology 2013;80:1684-1692.
49.
Corella D, Arnett DK, Tucker KL, Kabagambe EK, Tsai M, Parnell LD, Lai CQ, Lee YC, Warodomwichit D, Hopkins PN, Ordovas JM: A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and BMI. J Nutr 2011;141:2219-2225.
50.
Stickel F, Kessebohm K, Weimann R, Seitz HK: Review of liver injury associated with dietary supplements. Liver Int 2011;31:595-605.
51.
Cornelis MC, El-Sohemy A: Coffee, caffeine, and coronary heart disease. Curr Opin Clin Nutr Metab Care 2007;10:745-751.
52.
Josse AR, Da Costa LA, Campos H, El-Sohemy A: Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption. Am J Clin Nutr 2012;96:665-671.
53.
Da Costa LA, Garcia-Bailo B, Badawi A, El-Sohemy A: Genetic determinants of dietary antioxidant status. Prog Mol Biol Transl Sci 2012;108:179-200.
54.
Cuda C, Badawi A, Karmali M, El-Sohemy A: Polymorphisms in Toll-like receptor 4 are associated with factors of the metabolic syndrome and modify the association between dietary saturated fat and fasting high-density lipoprotein cholesterol. Metabolism 2011;60:1131-1135.
55.
Rapoport SI, Ramadan E, Basselin M: Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission. Prostaglandins Other Lipid Mediat 2011;96:109-113.
56.
Connor WE, Neuringer M, Lin DS: Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. J Lipid Res 1990;31:237-247.
57.
Connor WE, Lowensohn R, Hatcher L: Increased docosahexaenoic acid levels in human newborn infants by administration of sardines and fish oil during pregnancy. Lipids 1996;31(suppl):S183-S187.
58.
Bocarsly ME, Powell ES, Avena NM, Hoebel BG: High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels. Pharmacol Biochem Behav 2010;97:101-106.
59.
Sassone-Corsi P: Physiology. When metabolism and epigenetics converge. Science 2013;339:148-150.
60.
Ong TP, Perusse L: Impact of nutritional epigenomics on disease risk and prevention: introduction. J Nutrigenet Nutrigenomics 2011;4:245-247.
61.
Hyötyläinen T, Bondia-Pons I, Oresic M: Lipidomics in nutrition and food research. Mol Nutr Food Res 2013;57:1306-1318.
62.
Kang JX, Weylandt KH: Modulation of inflammatory cytokines by omega-3 fatty acids. Subcell Biochem 2008;49:133-143.
63.
Leaf A, Kang JX, Xiao YF: Fish oil fatty acids as cardiovascular drugs. Curr Vasc Pharmacol 2008;6:1-12.
64.
Kang JX: Balance of omega-6/omega-3 essential fatty acids is important for health. The evidence from gene transfer studies. World Rev Nutr Diet 2005;95:93-102.
65.
Wenk MR: The emerging field of lipidomics. Nat Rev Drug Discov 2005;4:594-610.
66.
Tuohy KM, Conterno L, Gasperotti M, Viola R: Up-regulating the human intestinal microbiome using whole plant foods, polyphenols, and/or fiber. J Agric Food Chem 2012;60:8776-8782.
67.
Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S: Host-gut microbiota metabolic interactions. Science 2012;336:1262-1267.
68.
Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O'Sullivan O, Fitzgerald GF, Deane J, O'Connor M, Harnedy N, O'Connor K, O'Mahony D, van Sinderen D, Wallace M, Brennan L, Stanton C, Marchesi JR, Fitzgerald AP, Shanahan F, Hill C, Ross RP, O'Toole PW: Gut microbiota composition correlates with diet and health in the elderly. Nature 2012;488:178-184.
69.
Gibson GR, Roberfroid MB: Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995;125:1401-1412.
70.
Collins MD, Gibson GR: Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999;69:1052S-1057S.
71.
Jacobs DM, Gaudier E, van Duynhoven J, Vaughan EE: Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics. Curr Drug Metab 2009;10:41-54.
72.
German JB, Watkins SM, Fay LB: Metabolomics in practice: emerging knowledge to guide future dietetic advice toward individualized health. J Am Diet Assoc 2005;105:1425-1432.
73.
Astarita G, Piomelli D: Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease. Prostaglandins Leukot Essent Fatty Acids 2011;85:197-203.
74.
Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, Connelly PW, Corey PN, El-Sohemy A: Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am J Clin Nutr 2007;86:768-774.
75.
Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS: Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010;304:1903-1911.
76.
Stonehouse W, Conlon CA, Podd J, Hill SR, Minihane AM, Haskell C, Kennedy D: DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. Am J Clin Nutr 2013;97:1134-1143.
77.
Thifault E, Cormier H, Bouchard-Mercier A, Rudkowska I, Paradis AM, Garneau V, Ouellette C, Lemieux S, Couture P, Vohl MC: Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation. J Nutrigenet Nutrigenomics 2013;6:73-82.
78.
Minihane AM, Khan S, Leigh-Firbank EC, Talmud P, Wright JW, Murphy MC, Griffin BA, Williams CM: ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 2000;20:1990-1997.
79.
Scalbert A, Brennan L, Fiehn O, Hankemeier T, Kristal BS, van Ommen B, Pujos-Guillot E, Verheij E, Wishart D, Wopereis S: Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 2009;5:435-458.
80.
Rainville PD, Stumpf CL, Shockcor JP, Plumb RS, Nicholson JK: Novel application of reversed-phase UPLC-oaTOF-MS for lipid analysis in complex biological mixtures: a new tool for lipidomics. J Proteome Res 2007;6:552-558.
81.
Castro-Perez JM, Kamphorst J, DeGroot J, Lafeber F, Goshawk J, Yu K, Shockcor JP, Vreeken RJ, Hankemeier T: Comprehensive LC-MS E lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients. J Proteome Res 2010;9:2377-2389.
82.
Castro-Perez J, Roddy TP, Nibbering NM, Shah V, McLaren DG, Previs S, Attygalle AB, Herath K, Chen Z, Wang SP, Mitnaul L, Hubbard BK, Vreeken RJ, Johns DG, Hankemeier T: Localization of fatty acyl and double bond positions in phosphatidylcholines using a dual stage CID fragmentation coupled with ion mobility mass spectrometry. J Am Soc Mass Spectrom 2011;22:1552-1567.
83.
Gasperotti M, Masuero D, Vrhovsek U, Guella G, Mattivi F: Profiling and accurate quantification of Rubus ellagitannins and ellagic acid conjugates using direct UPLC-Q-TOF HDMS and HPLC-DAD analysis. J Agric Food Chem 2010;58:4602-4616.
84.
Nicolaou A, Masoodi M, Mir A: Lipidomic analysis of prostanoids by liquid chromatography-electrospray tandem mass spectrometry. Methods Mol Biol 2009;579:271-286.
85.
Lundstrom SL, Saluja R, Adner M, Haeggstrom JZ, Nilsson G, Wheelock CE: Lipid mediator metabolic profiling demonstrates differences in eicosanoid patterns in two phenotypically distinct mast cell populations. J Lipid Res 2013;54:116-126.
86.
Giordano G, Di Gangi IM, Gucciardi A, Naturale M: Quantification of underivatised amino acids on dry blood spot, plasma, and urine by HPLC-ESI-MS/MS. Methods Mol Biol 2012;828:219-242.
87.
Gucciardi A, Pirillo P, Di Gangi IM, Naturale M, Giordano G: A rapid UPLC-MS/MS method for simultaneous separation of 48 acylcarnitines in dried blood spots and plasma useful as a second-tier test for expanded newborn screening. Anal Bioanal Chem 2012;404:741-751.
88.
Serhan CN, Samuelsson B: Lipoxins: a new series of eicosanoids (biosynthesis, stereochemistry, and biological activities). Adv Exp Med Biol 1988;229:1-14.
89.
Cortina MS, Bazan HE: Docosahexaenoic acid, protectins and dry eye. Curr Opin Clin Nutr Metab Care 2011;14:132-137.
90.
Vrhovsek U, Masuero D, Gasperotti M, Franceschi P, Caputi L, Viola R, Mattivi F: A versatile targeted metabolomics method for the rapid quantification of multiple classes of phenolics in fruits and beverages. J Agric Food Chem 2012;60:8831-8840.
91.
Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B: Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat 2012;97:73-82.
92.
Trim PJ, Henson CM, Avery JL, McEwen A, Snel MF, Claude E, Marshall PS, West A, Princivalle AP, Clench MR: Matrix-assisted laser desorption/ionization-ion mobility separation-mass spectrometry imaging of vinblastine in whole body tissue sections. Anal Chem 2008;80:8628-8634.
93.
Hart PJ, Francese S, Claude E, Woodroofe MN, Clench MR: MALDI-MS imaging of lipids in ex vivo human skin. Anal Bioanal Chem 2011;401:115-125.
94.
Djidja MC, Claude E, Snel MF, Francese S, Scriven P, Carolan V, Clench MR: Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue micro-array. Anal Bioanal Chem 2010;397:587-601.
95.
Vickerman JC: Molecular imaging and depth profiling by mass spectrometry - SIMS, MALDI or DESI? Analyst 2011;136:2199-2217.
96.
Nemes P, Vertes A: Atmospheric-pressure molecular imaging of biological tissues and biofilms by LAESI mass spectrometry. J Vis Exp 2010;43:pii2097.
97.
Franceschi P, Dong Y, Strupat K, Vrhovsek U, Mattivi F: Combining intensity correlation analysis and MALDI imaging to study the distribution of flavonols and dihydrochalcones in Golden Delicious apples. J Exp Bot 2012;63:1123-1133.
98.
Harris GA, Galhena AS, Fernandez FM: Ambient sampling/ionization mass spectrometry: applications and current trends. Anal Chem 2011;83:4508-4538.
99.
Li LP, Feng BS, Yang JW, Chang CL, Bai Y, Liu HW: Applications of ambient mass spectrometry in high-throughput screening. Analyst 2013;138:3097-3103.
100.
German JB, Zivkovic AM, Dallas DC, Smilowitz JT: Nutrigenomics and personalized diets: what will they mean for food? Annu Rev Food Sci Technol 2011;2:97-123.
101.
German JB, Roberts MA, Fay L, Watkins SM: Metabolomics and individual metabolic assessment: the next great challenge for nutrition. J Nutr 2002;132:2486-2487.
102.
Shion H: Distribution of biomarkers of interest in rat brain tissue using high definition MALDI imaging. Waters Corporation Technology Brief 2011:720004135en.
103.
Simopoulos AP: Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol Neurobiol 2011;44:203-215.
104.
Astarita G, Jung KM, Berchtold NC, Nguyen VQ, Gillen DL, Head E, Cotman CW, Piomelli D: Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS one 2010;5:e12538.
105.
Bourre JM: Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging 2004;8:163-174.
106.
Rosa AO, Rapoport SI: Intracellular- and extracellular-derived Ca(2+) influence phospholipase A(2)-mediated fatty acid release from brain phospholipids. Biochim Biophys Acta 2009;1791:697-705.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.